Amarin Corp plc (AMRN) Hit Enrollment Target for REDUCE-IT; Interim IDMC Analysis Planned
Tweet Send to a Friend
Amarin Corporation plc (Nasdaq: AMRN) announced that target patient enrollment has been reached in its REDUCE-IT cardiovascular outcomes trial of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
